Quality assessment in pancreatic cancer care: a review of the National Cancer Database

Jaap, Kathryn; Fluck, Marcus; Dove, James T.; Hunsinger, Marie; Arora, Tania K.; Shabahang, Mohsen; Blansfield, Joseph

doi:10.1016/j.jamcollsurg.2015.08.172

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition to oncologic treatment, other elements of management, including germline testing and the integration of supportive and palliative interventions, have an immense impact on the outcomes of patients with pancreatic cancer. In fact, comprehensive care is associated with improved survival in this population [ 4 ]. The degree to which comprehensive care is delivered across the U.S.’s pancreatic cancer population, however, is unknown.…”

Section: Introductionmentioning

confidence: 99%

Pancreatic Adenocarcinoma: Real World Evidence of Care Delivery in AccessHope Data

Barzi,

Kim,

Liang

et al. 2023

JPM

View full text Add to dashboard Cite

Background: Pancreatic adenocarcinoma is an aggressive disease and the delivery of comprehensive care to individuals with this cancer is critical to achieve appropriate outcomes. The identification of gaps in care delivery facilitates the design of interventions to optimize care delivery and improve outcomes in this population. Methods: AccessHope™ is a growing organization that connects oncology subspecialists with treating providers through contracts with self-insured employers. Data from 94 pancreatic adenocarcinoma cases (August 2019–December 2022) in the AccessHope dataset were used to describe gaps in care delivery. Results: In all but 6% of cases, the subspecialist provided guideline-concordant recommendations anticipated to improve outcomes. Gaps in care were more pronounced in patients with non-metastatic pancreatic cancer. There was a significant deficiency in germline testing regardless of the stage, with only 59% of cases having completed testing. Only 20% of cases were receiving palliative care or other allied support services. There was no difference in observed care gaps between patients receiving care in the community setting vs. those receiving care in the academic setting. Conclusions: There are significant gaps in the care delivered to patients with pancreatic adenocarcinoma. A concurrent subspecialist review has the opportunity to identify and address these gaps in a timely manner.

show abstract

Section: Introductionmentioning

confidence: 99%